| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
0.25 |
1 |
0.063 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
16 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
175 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
≤0.12 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
≤0.12 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
371 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.25 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
72 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
73 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
1 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
89 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
2 |
2 |
0.5 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
- |
0.5 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
89 |
| Staphylococci (coagulase-negative + methicillin-susceptible) |
- |
- |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
193 |